Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D et al
Monitoring of volume status and renal parameters is advisable Poorly controlled hypertension , where the interaction between retatrutide and existing antihypertensive regimens may be unpredictable A history of pancreatitis : in line with UK Summary of Product Characteristics (SmPC) wording for approved GLP-1-based therapies such as semaglutide (Wegovy) and tirzepatide (Mounjaro), retatrutide should be used with caution in patients with a history of pancreatitis, and discontinued promptly if acute pancreatitis is suspected Thyroid C-cell tumours : rodent studies with GLP-1 receptor agonists have identified C-cell hyperplasia and tumours
Understanding Rare but Serious Risks Every medical treatment has safety considerations, and GLP-1s are no exception
Portraying the decision to seek obesity treatments as being all about price makes it seem like the reason why someone would take this medication is because its affordable, not necessarily because it might be the right medication for them to take, Sneha Dave, executive director of the group, explained in an interview with MM+M
However, keeping a close watch on symptoms and following medical advice helps prevent small problems from becoming serious
We help schedule and manage your treatments for consistent results